06.11.2020 • NewsLummus Technology

Lummus Wins Russian Ethylene Contract

Lummus Technology has won a contract to supply 14 cracking furnaces for a gas chemical complex near Ust-Luga, Leningrad Oblast in Russia.

The contract was awarded within the framework of an engineering procurement and construction contract between China National Chemical Engineering & Construction Corporation Seven (CC7) and the Baltic Chemical Plant.

Lummus will provide engineering and its proprietary Short Residence Time (SRT) VI cracking furnaces, which will give a total ethylene capacity (crackers 1 and 2) of up to 3 million t/y. 

  
“The benefits offered by Lummus Technology include significant reduction in the output of by-products and specific consumption of utilities,” said Konstantin Makhov, general director of Baltic Chemical Plant. “The process also offers feedstock flexibility as it is possible to feed up to 10% propane in case of ethane shortage.”

CC7’s vice president Long Haiyang, also commented: “This is the first experience of partnering between Lummus Technology and CC7 for [an] ethylene integration project both in Russian and international markets. The relationships between the two companies have been evolving, and cooperation experience gained in this project will build a reliable foundation for future strategic partnership in the international market.”
  
The Baltic Chemical Plant complex is expected to produce about 3 million t/y of PE. A start-up date has not been disclosed.

Author: Elaine Burridge, Freelance Journalist

Lummus Technology will supply 14 cracking furnaces for a chemical complex near...
Lummus Technology will supply 14 cracking furnaces for a chemical complex near Ust-Luga in Russia. Lummus will provide engineering and its proprietary Short Residence Time cracking furnaces, which will give a total ethylene capacity (crackers 1 and 2) of up to 3 million t/y. (c) PilMo Kang

Company

Logo:

Lummus Technology

5825 North Sam Houston Pkwy W #600
77086 Houston, TX
US

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.